PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

Gene Therapy

Gene therapy approvals, outcomes evidence, site readiness, payer contracts, and one-time treatment access.

1 article·Lives underPipeline Pricing & Access·Last updated 2026-05-27

Pricing & Access· May 27, 2026 · 12 min read

Yescarta vs Tecartus CAR-T access guide: CD19-directed axi-cel vs brexu-cel payer coverage, REMS elimination, center certification, billing, and one-time authorization

By Ran Chen#Oncology #CAR-T #Prior Authorization